Biotin containing enzymes are found in all organisms and catalyze key steps in metabolic pathways. In humans, deficiencies in these enzymes can have serious, or catastrophic, consequences. In spite of continuing mechanistic and medical interest, little is known of the detailed structure and chemistry of this closely related family of proteins. The strategic goals of this research are to define the atomic details of the 1.3 S subunit of transcarboxylase (TC) and of its intermediate which has a carboxylate group transiently bound to the biotin cofactor. Multidimensional heteronuclear NMR will be used to solve the structures of the holo- and apo- 1.3 S protein in solution. The proteins will be labeled with 15N and/or 13C. The properties of the biotin co-factor on the protein, which relate to its function as a carboxylate acceptor, transporter and donor, will be elucidated by Raman and FTIR difference spectroscopies and by NMR. The structure and electron distribution in the carboxy-biotin complex on the 1.3 S subunit will be determined also by a combination of vibrational and NMR spectroscopies. In addition, changes in the protein s structure upon biotin carboxylation will be probed by NMR. Recent FTIR data indicate that after the CO2 moiety leaves the biotin ring on 1.3S via spontaneous decarboxylation, it remains associated witht he protein as an, as yet, uncharacterized complex. The complex will be identified using virbational spectroscopic techniques and NMR, in addition to experiments aimed at trapping the complex in a stable form using CH2N2. As a test of catalytic competence, the novel complex will be reacted with pyruvate in the presence of the 5S subunit to see if oxalacetate is formed. Vibrational spectroscopic analysis of biotin model compounds, of carboxy-biotin compounds and their isotopomers will be combined with quantum mechanical calculations to provide a basis for interpreting the data for biotin and carboxy-biotin on 1.3S.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Physical Biochemistry Study Section (PB)
Program Officer
Laughlin, Maren R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Case Western Reserve University
Schools of Medicine
United States
Zip Code
Carey, Paul R (2006) Spectroscopic characterization of distortion in enzyme complexes. Chem Rev 106:3043-54
Bethel, Christopher R; Hujer, Andrea M; Hujer, Kristine M et al. (2006) Role of Asp104 in the SHV beta-lactamase. Antimicrob Agents Chemother 50:4124-31
Carey, Paul R (2006) Raman crystallography and other biochemical applications of Raman microscopy. Annu Rev Phys Chem 57:527-54
Carey, Paul R; Dong, Jian (2004) Following ligand binding and ligand reactions in proteins via Raman crystallography. Biochemistry 43:8885-93
Hall, Pamela R; Zheng, Run; Pusztai-Carey, Marianne et al. (2004) Expression and crystallization of several forms of the Propionibacterium shermanii transcarboxylase 5S subunit. Acta Crystallogr D Biol Crystallogr 60:521-3
Carey, Paul R; Sonnichsen, Frank D; Yee, Vivien C (2004) Transcarboxylase: one of nature's early nanomachines. IUBMB Life 56:575-83
Zheng, Run; Zheng, Xiaojing; Dong, Jian et al. (2004) Proteins can convert to beta-sheet in single crystals. Protein Sci 13:1288-94
Hall, Pamela R; Zheng, Run; Antony, Lizamma et al. (2004) Transcarboxylase 5S structures: assembly and catalytic mechanism of a multienzyme complex subunit. EMBO J 23:3621-31
Zheng, Xiaojing; Rivera-Hainaj, Rosa E; Zheng, Yuangang et al. (2002) Substrate binding induces a cooperative conformational change in the 12S subunit of transcarboxylase: Raman crystallographic evidence. Biochemistry 41:10741-6
Wang, Y F; Hyatt , D C; Rivera, R E et al. (2001) Crystallization and preliminary X-ray analysis of the 12S central subunit of transcarboxylase from Propionibacterium shermanii. Acta Crystallogr D Biol Crystallogr 57:266-8

Showing the most recent 10 out of 14 publications